| DDI | Didanosine |
|---|
| didanosine | <chemical> A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. Didanosine is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase; ddi is then metabolised to dideoxyadenosine triphosphate, its putative active metabolite. Pharmacological action: anti-HIV agents, antimetabolites, reverse transcriptase inhibitors. Chemical name: Inosine, 2',3'-dideoxy- (12 Dec 1998) |
|---|
Synonyms : Bristol-Myers Brand of Didanosine, Bristol-Myers Squibb Brand of Didanosine, NSC-612049, Videx, 2', 3' Dideoxyinosine, Bristol Myers Brand of Didanosine, Bristol Myers Squibb Brand of Didanosine, NSC 612049, NSC612049
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|---|---|---|---|
|
바이덱스정100mg - 새창
|
BMS |
E03700041 | Didanosine | 전문의약품 | 급여 | 분업예외의약품 |
|
바이덱스EC서방형캅셀125mg - 새창
|
BMS |
E23350251 | Didanosine | 전문의약품 | 급여 | 분업예외의약품 |
|
바이덱스EC서방형캅셀200mg - 새창
|
BMS |
E23350261 | Didanosine | 전문의약품 | 급여 | 분업예외의약품 |
|
바이덱스EC서방형캅셀250mg - 새창
|
BMS |
E23350271 | Didanosine | 전문의약품 | 급여 | 분업예외의약품 |
|
바이덱스EC서방형캅셀400mg - 새창
|
BMS |
E23350281 | Didanosine | 전문의약품 | 급여 | 분업예외의약품 |
| didanosine |
A drug used in the treatment of infections caused by viruses.
출처: www.stjude.org/glossary
|
|---|---|
| didanosine |
A nucleoside reverse transcriptase inhibitor first approved by the FDA in 1991 and used for the treatment of HIV infection when antiretroviral therapy is warranted. Also called ddl, Videx.
출처: www.thebody.com/hivatis/glossary/d.html
|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|